211 related articles for article (PubMed ID: 7860774)
1. Cell density and paradoxical transcriptional properties of c-Myc and Max in cultured mouse fibroblasts.
Lee LA; Resar LM; Dang CV
J Clin Invest; 1995 Feb; 95(2):900-4. PubMed ID: 7860774
[TBL] [Abstract][Full Text] [Related]
2. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
[TBL] [Abstract][Full Text] [Related]
5. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu W; Cechova K; Tassi V; Dalla-Favera R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
8. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
Arsura M; Deshpande A; Hann SR; Sonenshein GE
Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
[TBL] [Abstract][Full Text] [Related]
9. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
10. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
Desbarats L; Gaubatz S; Eilers M
Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
[TBL] [Abstract][Full Text] [Related]
12. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
13. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
[TBL] [Abstract][Full Text] [Related]
15. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
16. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
17. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
Tobias KE; Shor J; Kahana C
Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
[TBL] [Abstract][Full Text] [Related]
18. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.
Solomon DL; Amati B; Land H
Nucleic Acids Res; 1993 Nov; 21(23):5372-6. PubMed ID: 8265351
[TBL] [Abstract][Full Text] [Related]
19. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.
Swanson HI; Yang JH
Nucleic Acids Res; 1999 Aug; 27(15):3205-12. PubMed ID: 10454619
[TBL] [Abstract][Full Text] [Related]
20. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
James L; Eisenman RN
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]